A detailed history of Kistler Tiffany Companies, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 10,803 shares of AMGN stock, worth $3.49 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
10,803
Previous 10,753 0.46%
Holding current value
$3.49 Million
Previous $2.6 Million 7.73%
% of portfolio
0.39%
Previous 0.5%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$214.27 - $253.37 $10,713 - $12,668
50 Added 0.46%
10,803 $2.4 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $1,580 - $1,926
7 Added 0.07%
10,753 $2.6 Million
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $20,154 - $25,608
88 Added 0.83%
10,746 $2.82 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $32,097 - $36,200
-143 Reduced 1.32%
10,658 $2.4 Million
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $113,740 - $126,572
493 Added 4.78%
10,801 $2.63 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $17,760 - $19,648
-81 Reduced 0.78%
10,308 $2.49 Million
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $6,364 - $7,283
32 Added 0.31%
10,389 $2.34 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $92,549 - $108,433
436 Added 4.39%
10,357 $2.2 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $430,254 - $477,335
-1,842 Reduced 15.66%
9,921 $2.42 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $15,977 - $18,619
-72 Reduced 0.61%
11,763 $2.93 Million
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $14,713 - $17,521
-68 Reduced 0.57%
11,835 $2.72 Million
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $59,835 - $66,542
-255 Reduced 2.1%
11,903 $3.03 Million
Q2 2020

Jul 20, 2020

SELL
$197.81 - $242.74 $52,617 - $64,568
-266 Reduced 2.14%
12,158 $2.87 Million
Q4 2019

Jan 14, 2020

SELL
$189.21 - $243.2 $25,921 - $33,318
-137 Reduced 1.09%
12,424 $3 Million
Q3 2019

Oct 18, 2019

BUY
$174.11 - $208.62 $13,928 - $16,689
80 Added 0.64%
12,561 $2.43 Million
Q2 2019

Jul 22, 2019

SELL
$166.7 - $195.41 $10,002 - $11,724
-60 Reduced 0.48%
12,481 $2.3 Million
Q1 2019

Apr 16, 2019

SELL
$180.87 - $203.88 $67,283 - $75,843
-372 Reduced 2.88%
12,541 $2.38 Million
Q4 2018

Jan 14, 2019

SELL
$178.4 - $208.25 $25,154 - $29,363
-141 Reduced 1.08%
12,913 $2.51 Million
Q3 2018

Oct 19, 2018

SELL
$185.29 - $208.89 $31,869 - $35,929
-172 Reduced 1.3%
13,054 $2.71 Million
Q2 2018

Jul 17, 2018

SELL
$166.05 - $186.51 $108,762 - $122,164
-655 Reduced 4.72%
13,226 $2.44 Million
Q1 2018

Apr 06, 2018

SELL
$169.43 - $198.0 $120,464 - $140,778
-711 Reduced 4.87%
13,881 $2.37 Million
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $72,242 - $80,716
428 Added 3.02%
14,592 $2.54 Million
Q3 2017

Oct 19, 2017

BUY
$167.29 - $191.0 $2.37 Million - $2.71 Million
14,164
14,164 $2.64 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.